A Meta-Analysis of Efficacy and Safety of PD-1/PD-L1 Inhibitors in Triple-Negative Breast Cancer

Figure 5

Forest plots of AEs. (a) All-grade AEs. (b) Grade ≥3 AEs. (c) SAEs. SE: standard error; CI: confidence interval; TNBC: triple-negative breast cancer; PD: progression death; AEs: adverse events; SAEs: severe adverse events.

(a)

(b)

(c)